Shares of ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $8.17, but opened at $8.53. ASP Isotopes shares last traded at $8.75, with a volume of 1,999,896 shares.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group boosted their target price on shares of ASP Isotopes from $8.50 to $11.00 and gave the company a "buy" rating in a research note on Wednesday, May 21st.
Get Our Latest Research Report on ASP Isotopes
ASP Isotopes Stock Performance
The company has a debt-to-equity ratio of 0.80, a current ratio of 7.21 and a quick ratio of 7.17. The stock has a 50-day simple moving average of $7.77 and a 200-day simple moving average of $6.05. The stock has a market cap of $879.90 million, a P/E ratio of -17.20 and a beta of 3.35.
Institutional Investors Weigh In On ASP Isotopes
Several institutional investors have recently bought and sold shares of the stock. Two Sigma Investments LP purchased a new position in shares of ASP Isotopes during the 4th quarter valued at $1,980,000. JPMorgan Chase & Co. lifted its holdings in ASP Isotopes by 854.6% during the 4th quarter. JPMorgan Chase & Co. now owns 211,893 shares of the company's stock worth $960,000 after purchasing an additional 189,697 shares in the last quarter. BNP Paribas Financial Markets purchased a new stake in ASP Isotopes during the 4th quarter worth about $34,000. Price T Rowe Associates Inc. MD lifted its holdings in ASP Isotopes by 14.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 21,646 shares of the company's stock worth $99,000 after purchasing an additional 2,757 shares in the last quarter. Finally, ProShare Advisors LLC purchased a new stake in ASP Isotopes during the 4th quarter worth about $67,000. Institutional investors own 16.80% of the company's stock.
About ASP Isotopes
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
See Also
Before you consider ASP Isotopes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.
While ASP Isotopes currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
